Gene therapy targeting SARM1 blocks pathological axon degeneration in mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gene therapy targeting SARM1 blocks pathological axon degeneration in mice
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume -, Issue -, Pages jem.20181040
Publisher
Rockefeller University Press
Online
2019-01-15
DOI
10.1084/jem.20181040
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury
- (2018) Kimberly A. Fernandes et al. EXPERIMENTAL EYE RESEARCH
- Two breakthrough gene-targeted treatments for spinal muscular atrophy: challenges remain
- (2018) Charlotte J. Sumner et al. JOURNAL OF CLINICAL INVESTIGATION
- Primary Traumatic Axonopathy in Mice Subjected to Impact Acceleration: A Reappraisal of Pathology and Mechanisms with High-Resolution Anatomical Methods
- (2018) Nikolaos K. Ziogas et al. JOURNAL OF NEUROSCIENCE
- Nigrostriatal dopamine transporter availability in early Parkinson's disease
- (2018) Patrik Fazio et al. MOVEMENT DISORDERS
- Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's disease
- (2018) Gerard W. O'Keeffe et al. PARKINSONISM & RELATED DISORDERS
- Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy
- (2017) Elliot Turkiew et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD + Cleavage Activity that Promotes Pathological Axonal Degeneration
- (2017) Kow Essuman et al. NEURON
- Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
- (2017) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sarm1 Deletion, but Not Wld S , Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy
- (2017) Jonathan Gilley et al. Cell Reports
- Axonal damage and loss of connectivity in nigrostriatal and mesolimbic dopamine pathways in early Parkinson's disease
- (2017) Silvia Paola Caminiti et al. NeuroImage-Clinical
- Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice
- (2016) Stefanie Geisler et al. BRAIN
- Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lackingSarm1
- (2016) Nils Henninger et al. BRAIN
- Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism
- (2016) Josiah Gerdts et al. NEURON
- SARM1-specific motifs in the TIR domain enable NAD+loss and regulate injury-induced SARM1 activation
- (2016) Daniel W. Summers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Retrograde Axonal Degeneration in Parkinson Disease
- (2016) Patricia Tagliaferro et al. Journal of Parkinsons Disease
- NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD+ depletion
- (2016) Yo Sasaki et al. eLife
- Toll/interleukin-1 receptor (TIR) domain-mediated cellular signaling pathways
- (2015) Kannan Badri Narayanan et al. APOPTOSIS
- Pathological Axonal Death through a MAPK Cascade that Triggers a Local Energy Deficit
- (2015) Jing Yang et al. CELL
- Mechanisms of distal axonal degeneration in peripheral neuropathies
- (2015) Christopher R. Cashman et al. NEUROSCIENCE LETTERS
- SARM1 activation triggers axon degeneration locally via NAD+ destruction
- (2015) J. Gerdts et al. SCIENCE
- Absence of SARM1 Rescues Development and Survival of NMNAT2-Deficient Axons
- (2015) Jonathan Gilley et al. Cell Reports
- Wallerian degeneration: an emerging axon death pathway linking injury and disease
- (2014) Laura Conforti et al. NATURE REVIEWS NEUROSCIENCE
- Sarm1-Mediated Axon Degeneration Requires Both SAM and TIR Interactions
- (2013) J. Gerdts et al. JOURNAL OF NEUROSCIENCE
- Axon degeneration in Parkinson's disease
- (2012) Robert E. Burke et al. EXPERIMENTAL NEUROLOGY
- Intrinsic axonal degeneration pathways are critical for glaucomatous damage
- (2012) Gareth R. Howell et al. EXPERIMENTAL NEUROLOGY
- Axonal pathology in traumatic brain injury
- (2012) Victoria E. Johnson et al. EXPERIMENTAL NEUROLOGY
- Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
- (2012) Gabriele Mittermeyer et al. HUMAN GENE THERAPY
- dSarm/Sarm1 Is Required for Activation of an Injury-Induced Axon Death Pathway
- (2012) J. M. Osterloh et al. SCIENCE
- Gene Therapy for Aromatic L-Amino Acid Decarboxylase Deficiency
- (2012) W.-L. Hwu et al. Science Translational Medicine
- The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration
- (2010) Gerd Meyer zu Horste et al. NEUROBIOLOGY OF DISEASE
- Nicotinamide Mononucleotide Adenylyl Transferase-Mediated Axonal Protection Requires Enzymatic Activity But Not Increased Levels of Neuronal Nicotinamide Adenine Dinucleotide
- (2009) Y. Sasaki et al. JOURNAL OF NEUROSCIENCE
- The Immune Adaptor Molecule SARM Modulates Tumor Necrosis Factor Alpha Production and Microglia Activation in the Brainstem and Restricts West Nile Virus Pathogenesis
- (2009) K. J. Szretter et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More